Skip to main content
Have a personal or library account? Click to login

References

  1. Anonīms (2007). Latvijas vēža registrs [Cancer Registry of Latvia]. Riga, Latvia (in Latvian).
  2. Anonymous (2002). Globocan 2002. International Agency for Research on Cancer.
  3. Aretz, S., Stienen, D., Friedrichs, N., Stemmler, S., Uhlhaas, S., Rahner, N., Friedl, W. (2007). Somatic APC mosaicism: A frequent cause of familial adenomatous polyposis (FAP).,(10), 985-992.
  4. Bartch, D.K., Kress, R., Sina-Frey, M., Grutzman, R., Gerdes, B., Pilarsky, C., Heise, J.V., Schulte, K.M., Ghadimi, M.B., Horstmann, O., Schmidt, J., Eisold, S., Hahn, S.A., Schulmann, K., Bock, W., Gress, T.M., Zugel, N., Prenzel, K., Messmann, H., Enlicher, E., Schneider, M., Ziegler, M., Schmiegel, K., Rothmund, M., Rieder, H. (2004). Epidemiology. Prevalence of familial pancreatic cancer in Germany.,(6), 902-906.
  5. Bisgaard, M., Ripa, R., Bülow, S. (2004). Mutation analysis of the adenomatous polyposis coli () gene in Danish patients with familial adenomatous polyposis (FAP)., No. 705, http://www3.interscience.wiley.com/homepages/38515/pdf/mutation/705.pdf
  6. Boltenberg, A., Furgyik, S., Kullander, S. (1990). Familial cancer agregation in cases of adenocarcinoma corporis uteri.,, 249-258.
  7. Bratt, O. (2000). Hereditary prostate cancer.(5), 588-98.
  8. Bülow, S., Nielsen, T., Bülow, C., Bisgaard, M.L., Karlsen, L., Moesgaard, F. (1996). The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register.,(2), 88-91.
  9. Calin, G.A., Trapasso, F., Shimizu, M., Dumitru, C.D., Godwin, A.K., Ferracin, M., Bernardi, G., Rattan, S., Alder, H., Mabuchi, H., Overgaard, J., Mauro, F.R., Neuberg, D., Bullrich, F., Negrini, M., Croce, C.M. (2005). Familial cancer associated with a polymorphism in,, 1667-1676.
  10. Chapelle, A., de la (2004). Genetic predisposition to colorectal cancer.,(10), 769-780.
  11. Chiaro, M., Presciuttini, S., Bertacca, L., Zerbi, A., Longoni, B.M., Cipollini, G., Caligo, M.A., Boggi, U., Civitelli, V., Falconi, M., Pederzoli, P., Di Carlo, V., Cavallini, G., Mosca, F. (2005). Cancer risk among relatives of probands with pancreatic ductal adenocarcinoma.,(1), 76.
  12. Csokay, B., Tihomirova, L., Stengrevics, A., Sinicka, O., Olah, E. (1999). Strong founder effects inmutation carrier breast cancer patients from Latvia.,, 92.
  13. Cybulski, C., Górski, B., Debniak, T., Gliniewicz, B., Mierzejewski, M., Masojc, B., Jakubowska, A., Matyjasik, J., Zlowocka, E., Sikorski, A., Narod, S.A., Lubinski, J. (2004).is a prostate cancer susceptibility gene.,(4), 1215-1219.
  14. Cybulski, C., Huzarski, T., Górski, B., Masojc, B., Mierzejewski, M., Debniak, T., Gliniewicz, B., Matyjasik, J., Zlowocka, E., Kurzawski, G., Sikorski, A., Posmyk, M., Szwiec, M., Czajka, R., Narod, S.A., Lubinski, J. (2004). A novel foundermutation is associated with increased prostate cancer risk.,(8), 2677-2679.
  15. Cybulski, C., Górski, B., Gronwald, J., Huzarski, T., Byrski, T., Debniak, T., Jakubowska, A., Wokolorczyk, D., Gliniewicz, B., Sikorski, A., Stawicka, M., Godlewski, D., Kwias, Z., Antczak, A., Borkowski, T., Szwiec, M., Posmyk, M., Narod, S.A., Lubiński, J. (2008).mutations and prostate cancer in Poland.,, 62-66.
  16. Debniak, T., Scott, R.J., Huzarski, T., Byrski, T., Rozmiarek, A., Debniak, B., Gorski, B., Cybulski, C., Medrek, K., Masojc, B., Lener, M., Jaworowska, E., Oszutowska, D., Szymanska, A., Castaneda, J., Wetering, T., Suchy, J., Kurzawski, G., Oszurek, O., Narod, S., Lubinski, J. (2006).common variant and multi-organ cancer risk - a population-based study.,(12), 3180-3182.
  17. Debniak, T., Cybulski, C., Kurzawski, G., Górski, B., Huzarski, T. (2006). Low-risk genes and multi-organ cancer risk in the Polish population.,(1), 52-55.
  18. Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D. (1998). Genetic heterogeneity and penetrance analysis of theandgenes in breast cancer families. The Breast Cancer Linkage Consortium.,(3), 676-689.
  19. Frank, B., Hemminki, K., Meindl, A., Wappenschmidt, B., Klaes, R., Schmutzler, R., Untch, M., Bugert, P., Bartram, C.R., Burwinkel, B. (2006). Association of theCys148Arg variant with familial breast cancer risk.,, 2505-2508.
  20. Fromont, G., Yacoub, M., Valeri, A., Mangin, P., Vallancien, G., Cancel-Tassin, G., Cussenot, O. (2008). Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancer.,, 1505-1509.
  21. Górski, B., Byrski, T., Huzarski, T. (2000). Founder mutations in thegene in Polish families with breast-ovarian cancer.,, 1963-1968.
  22. Gronwald, J., Huzarski, T., Oszurek, O., Janicka, A., Szymańska-Pasternak, J., Górski, B., Menkiszak, J., Rzepka-Górska, I., Lubiński, J. (2008). Hereditary breast and ovarian cancer.,(2), 88-98.
  23. Gronwald, J., Elsakob, P., Gorski, B., Lubinski, J. (2005). High incidence of 4153delAgene mutations in Lithuanian breast- and breast-ovarian cancer families.,(2), 111-113.
  24. Hahn, S.A., Greenhalf, B., Ellis, I., Sine-frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Campra, D., Grutzmann, R., Rehder, H., Rothmund, M., Schmiegel, W., Neoptolemos, J.P., Bartsch, D.K. (2003).germline mutations in familial pancreatic carcinoma.,, 214-221.
  25. Hughes, C., Murphy, A., Martin, C., Sheils, O., O'Leary, J. (2005). Molecular pathology of prostate cancer.,, 673-684.
  26. Jarvinen, H.J. (1992). Epidemiology of familial adenomatous polyposis in Finland: Impact of family screening on the colorectal cancer rate and survival.,(3), 357-360.
  27. Jacobi, C.E., Jonker, M.A., Nagelkerke, N., van Houwelingen, J., Bock, G.H. (2003). Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care.,(7), e83.
  28. Jemal, A., Thomas, A., Murray, T., Thun, M. (2002). Cancer statistics.,, 23-47.
  29. John, E.M. (2004). The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.,(4), R375-389.
  30. Kilpivaara, O., Laiho, L., Aaltonen, A., Nevanlinna, H. (2003).1100delC and colorectal cancer.,(10), 110.
  31. Kurzawski, G., Suchy, J., Kladny, J., Grabowska, E., Jakubowska, A., Debniak, T., Cybulski, C., Kowalska, E., Szych, Z., Domagala, W., Scott, R.J., Lubinski, J. (2004). The3020insC mutation and the risk of colorectal cancer.(5), 1604-1606.
  32. Levy-Lahad, E. (1997). Founderandmutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.,(5), 1059-1067.
  33. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo M., Pukkala E., Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland.,, 78-85.
  34. Lynch, H.T., Lanspa, S., Smyrk, B.B., Watson, P., Lynch, J. (1991). Hereditary non-polyposis colorectal cancer (Lynch syndromes I and II) genetics, pathology, natural history and cancer control, Part I.,, 143-160.
  35. Martin, A.M., Blackwood, M.A., Antin-Ozerkis, D., Shih, H.A., Calzone, K., Colligon, T., Seal, S., Collins, N., Stratton, M.R., Weber, B.L., Nathanson, K.L. (2001). Germline mutations inandin breast-ovarian families from a breast cancer risk evaluation clinic.,(8), 2247-2253.
  36. Masojc, B., Mierzejewski, M., Cybulski, C., Wetering, T., Debniak, T., Gorski, B., Jaworowska, E., Tarnowska, C., Lenner, M., Scott, R.J., Lubinski, J. (2006). Cancer Familial Aggregation (CFA) and G446A polymorphism ingene.,(1), 59-62.
  37. Mecklin, J.-P., Jarvinen, H.I. (1991). Tumor spectrum in cancer-family syndroma.,, 1109-1112.
  38. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Duerr, R., Achkar, R., Brant, S., Bayless, T., Kirschner, B., Hanauer, S., Nunez, G., Cho, J.H. (2001). A frameshift mutation inassociated with susceptibility to Crohn's disease.,(6837), 603-606.
  39. Oszurek, O., Gorski, B., Gronwald, J., Prosolow, Z., Uglanica, K., Murinow, A., Bobko, I., Norik, D., Byrski, T., Jakubowska, A., Lubinski, J. (2001). Founder mutations in thegene in west Belarusian breast-ovarian cancer families.,(6), 470-471.
  40. Ollikainen, M., Abdel-Rahman, W., Moisio, A., Lindroos, A., Kariola, R., Jarvela, I., Poyhonen, M., Butzow, R., Peltomaki, P. (2005). Molecular analysis of familial endometrial carcinoma: A manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome.,(21), 4609-4616.
  41. Pohlreich, P. (2005). High proportion of recurrent germline mutations in thegene in breast and ovarian cancer patients from the Prague area.,(5), R728-736.
  42. Rennert, H., Zeigler-Johnson, C., Addya, K., Finley, M., Walker, A., Spangler, E., Leonard, D., Wein, A., Malkowicz, S., Rebbeck, T. (2005). Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, andwith prostate cancer severity in European American and African American men.,(4), 949-957.
  43. Sandles, L.G. (1998). Familial endometrial adenocarcinoma.,, 167-171.
  44. Santarosa, M., Liede, A., Aube, J., Finch, A., Kwan, E., Jack, E., Narod, S., Randall, S., Hugel, L., Clark, K. (1999).andgenes: Role in hereditary breast and ovarian cancer in Italy.,(1), 5-9.
  45. Sinicka, O., Stengrevics, A., Eglitis, J., Smite, D., Shomshteine, Z., Tihomirova, L. (2004). Ovarian cancer in Latvia is attributable to recurrent mutations in thegene.,, 17-25.
  46. Suomi, R., Hakala, T., Pietila, A., Laminen, A., Mecklin, J.-P., Lehtovirta, P. (1995). Hereditary aspects of endometrial adenocarcinoma.,, 132-137.
  47. Stacey, S.N., Sulem, P., Johannsson, O., Helgason, A., Gudmundsson, J., Kostic, J., Kristjansson, K., Sveinsson, T., Myrdal, G., Grimsson, H., Kong, A., Stefansson, K. (2006). TheCys557Ser variant and breast cancer risk in Iceland.,(7), e217.
  48. Thompson, D., Easton, D.F. (2002). Cancer incidence inmutation carriers.,(18), 1358-1365.
  49. Tikhomirova, L., Sinicka, O., Smite, D., Hodgson, S.V., Stengrevics, A. (2005). High prevalence of twomutations, 4154delA and 5382insC in Latvia.,, 77-84.
  50. Vasen, H.F. (2001).Stichting Opsporing Erfelijke Tumoren & Vereniging klinische Genetica Nederland Werkgroep Klinische Oncogenetica. 21.
DOI: https://doi.org/10.2478/v10046-009-0042-5 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 131 - 140
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2009 Jānis Gardovskis, Ilze Štrumfa, Edvīns Miklaševičs, Arvīds Irmejs, Genādijs Trofimovičs, Egils Vjaters, Viktors Borošenko, Inga Melbārde-Gorkuša, Andris Gardovskis, Andrejs Vanags, Andris Ābele, Signe Subatniece, Marianna Bitiņa, Liāna Švampāne, Jekaterina Žestkova, Dace Bērziņa, Karina Aksenoka, Viesturs Boka, Aldis Puķītis, Aiga Stāka, Laima Tihomirova, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.